Cretex Medical has broken ground on a new production facility in Cartago, Costa Rica. The 65,000-square-foot facility will serve as a place for medical device component manufacturing and assembly. 

 

It will include state-of-the-art technology and manufacturing equipment with operations targeted to begin in Q3 2025.

 

“As a family-owned, purpose-driven company, Cretex sought a location that aligned with both our business needs and our core values,” said Jeff Wollerman, CEO and President of Cretex Companies. “Costa Rica’s cultural emphasis on family and community, coupled with its status as a leading manufacturer of medical devices, made it an ideal match.”

 

Cretex Medical plans to invest over $20,000,000 in Costa Rica operations over the next few years, with a second expansion already in mind.

 

“Whenever we make an investment, the needs of our customers are central to our decision-making. As our customers continue to grow, it’s clear now is the right time to add an international footprint,” said Nick Morrison, Chief Operating Officer of Cretex Companies. “We evaluated a variety of countries and communities. We knew that we needed a location that brought us into proximity with our global customers. It also had to have a labor market with the right technical skills and talent, while aligning with our domestic operations.”

 

Having the new facility in Costa Rica puts the company close to its customers and in an area of success, seeing as medical technology is Costa Rica’s main exported product. Costa Rica’s time zone also aligns with Cretex Medical’s U.S. facilities, making collaboration easier.